One idea for treating disease is to be able to program cells. Now, a major advance in synthetic biology allows for that kind of control that hasn't been seen before. The Institute for Protein Design...
(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
Pamela Becker, a UW professor of medicine (hematology) and a faculty member at the Institute for Stem Cell and Regenerative Medicine, and Su-In Lee, UW associate professor of computer sciences and...
A UW Medicine breast cancer expert discusses a recent prominent study indicating that the most common breast cancer is more insidious than previously understood. See related Q&A with Dr. Nancy...
Type: Upload file
Artist impression of designed mini-protein binders targeting Influenza hemagglutinin to effectively bind and neutralize the virus.
It's the question many ask: Is there a safe amount to drink during pregnancy? A new study published in Advances in Pediatric Research suggests the answer is no. Susan Astley Hemingway, professor of...
Interleukin-2 (IL-2) is a molecule that amps up immune cells to fight off infections. While it is effective, the problem with IL-2 is that it causes a lot of toxicity in patients. Researchers at the...
Bioengineers have cleared a major hurdle on the path to 3D printing replacement organs. It's a breakthrough technique for bioprinting tissues with exquisitely entangled vascular networks that mimic...
The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry. Through computer...
Open surgery has long been the convention for treating aortic stenosis, a potentially lethal condition in which a failing aortic valve reduces blood flow from the heart. But TAVR, or transcatheter...